Problem statement: Answer the MCQ question.
Question: Which drug exhibits a -90.225% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a. Br.CC1(C(=O)CSc2n[nH]c(-c3ccccc3Cl)n2)CCC(=O)O1
b. COC(=O)C1(C)NC(c2ccco2)C2C(=O)N(c3ccc(C)cc3)C(=O)C21
c. COC(=O)C1=C(C)N(Cc2ccccc2)C(=NCCCCO)N[C@H]1c1ccccc1
d. Cc1ccc(-c2ccc(/C=N/NC(=O)CN3CCCC3)o2)cc1Cl
e. CNCCOc1ccc(Cl)c(Cl)c1.O=C(O)C(=O)O
Answer: d. Cc1ccc(-c2ccc(/C=N/NC(=O)CN3CCCC3)o2)cc1Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(-c2ccc(/C=N/NC(=O)CN3CCCC3)o2)cc1Cl
Cc1ccc(-c2ccc(/C=N/NC(=O)CN3CCCC3)o2)cc1Cl
N-[(E)-[5-(3-chloro-4-methylphenyl)furan-2-yl]methylideneamino]-2-pyrrolidin-1-ylacetamide